3696.HK+33.10%16.7%
ARQT+88.47%16.7%
HALO+36.42%16.7%
OBIO+30.67%16.7%
VCEL+17.17%16.7%
WVE-20.63%16.7%
As of Jul 10, 2026, 7:14 AM ET
MedTech Long '25: Adv Bio Therapeutics & Regenerative Med Constituents
| Company | Wgt | Premarket % | 1D % | 10D % | MTD % | YTD % | IranWar % | LibDay % | 1Yr % | Mkt Cap |
|---|---|---|---|---|---|---|---|---|---|---|
Halozyme Therapeutics, Inc.HALO | 16.7% | -0.14% | -2.18% | 1.87% | 2.09% | 16.82% | 13.07% | 24.75% | 36.42% | $9.33B |
Arcutis Biotherapeutics, Inc.ARQT | 16.7% | 1.58% | 0.98% | 7.55% | 11.38% | -0.90% | 6.71% | 73.37% | 88.47% | $3.60B |
InSilico Medicine Cayman TopCo3696.HK | 16.7% | 7.48% | 7.68% | -3.65% | 0.63% | 6.52% | -35.79% | 31.96% | 33.10% | $2.91B |
Vericel CorporationVCEL | 16.7% | 0.00% | 2.74% | 7.19% | 7.00% | 34.16% | 35.40% | 9.03% | 17.17% | $2.47B |
Wave Life Sciences Ltd.WVE | 16.7% | -0.16% | 1.12% | 11.09% | 8.05% | -62.88% | -54.70% | -16.64% | -20.63% | $1.21B |
Orchestra BioMed Holdings, Inc.OBIO | 16.7% | 5.87% | 0.00% | -17.47% | -8.84% | -5.54% | -10.50% | 11.36% | 30.67% | $234.7M |
| Theme return | — | 2.44% | 1.72% | 1.10% | 5.89% | 2.95% | -4.49% | 38.51% | 41.62% | — |
| Average | 16.7% | 2.44% | 1.72% | 1.10% | 3.39% | -1.97% | -7.64% | 22.31% | 30.87% | $3.29B |
| Median | 16.7% | 0.79% | 1.05% | 4.53% | 4.55% | 2.81% | -1.89% | 18.06% | 31.89% | $2.69B |
| Std Dev | 0.0% | 3.09% | 3.05% | 9.54% | 6.55% | 30.15% | 30.28% | 27.45% | 32.13% | $2.92B |
| Min | 16.7% | -0.16% | -2.18% | -17.47% | -8.84% | -62.88% | -54.70% | -16.64% | -20.63% | $234.7M |
| Max | 16.7% | 7.48% | 7.68% | 11.09% | 11.38% | 34.16% | 35.40% | 73.37% | 88.47% | $9.33B |
| % Positive Tickers | 50.00% | 66.67% | 66.67% | 83.33% | 50.00% | 50.00% | 83.33% | 83.33% |
About this theme
MedTech Long '25: Adv Bio Therapeutics & Regenerative Med tracks 6 publicly listed stocks in this theme: 3696.HK, ARQT, HALO, OBIO, VCEL, WVE. See the constituent table for details.